These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8971853

  • 1. Anomalies in hepatobiliary excretion of technetium-99m-MAG3 preparations.
    Chatterjee M, Majumder A, Iyer P, Muthukrishnan G, Das MK, Ramamoorthy N, Desai CN, Banerjee S.
    Nucl Med Biol; 1996 Oct; 23(7):867-72. PubMed ID: 8971853
    [Abstract] [Full Text] [Related]

  • 2. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR, Robbins MS.
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
    Bannister KM, Penglis S, Bellen JC, Baker RJ, Chatterton BE.
    J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Formulation of lyophilized single vial kit of N-N-Ethylene-L-Dicysteine (EC) for labeling with 99mTc. II: Radiochemical and clinical evaluation as a renal tubular agent in comparison with 99mTc-MAG3.
    Afshan A, Sohaib M, Jehangir M.
    Pak J Pharm Sci; 2017 Jul; 30(4):1289-1295. PubMed ID: 29039327
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Factors affecting the hepatobiliary excretion of 99mTc-MAG3: its clinical significance in routine renography.
    Arroyo AJ, Semaan HB, Minkus KD, Patel YP.
    J Nucl Med Technol; 2003 Mar; 31(1):18-20. PubMed ID: 12624122
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L, Turoğlu HT, Onsel C, Ozker K, Uslu I, Atay S, Cansiz T, Sönmezoğlu K, Altiok E, Isitman AT.
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. 3'-99mTc-labeling and biodistribution of a CAPL antisense oligodeoxynucleotide.
    Hjelstuen OK, Tønnesen HH, Bremer PO, Verbruggen AM.
    Nucl Med Biol; 1998 Oct; 25(7):651-7. PubMed ID: 9804046
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement.
    Fritzberg AR, Kasina S, Eshima D, Johnson DL.
    J Nucl Med; 1986 Jan; 27(1):111-6. PubMed ID: 2934521
    [Abstract] [Full Text] [Related]

  • 18. Complexes of technetium-99m with tetrapeptides containing one alanyl and three glycyl moieties.
    Vanbilloen HP, De Roo MJ, Verbruggen AM.
    Eur J Nucl Med; 1996 Jan; 23(1):40-8. PubMed ID: 8586100
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Determination of extrarenal plasma clearance and hepatic uptake of technetium-99m-mercaptoacetyltriglycine in cats.
    Drost WT, McLoughlin MA, Mattoon JS, Lerche P, Samii VF, DiBartola SP, Chew DJ, Barthez PY.
    Am J Vet Res; 2003 Sep; 64(9):1076-80. PubMed ID: 13677382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.